Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: The elain randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 315, Issue 20, 2016, Pages 2190-2199

  Zarbock, Alexander ^a   Kellum, John A ^b   Schmidt, Christoph ^a   Van Aken, Hugo ^a   Wempe, Carola ^a   Pavenstädt, Hermann ^a   Boanta, Andreea ^a   Gerß, Joachim ^c   Meersch, Melanie ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATININE; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; MIGRATION INHIBITION FACTOR; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY INTERVENTION; ENZYME BLOOD LEVEL; EXPLORATORY RESEARCH; FEMALE; FLUID RESUSCITATION; FOLLOW UP; GERMANY; HAZARD RATIO; HOSPITALIZATION; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY DISEASE IMPROVING GLOBAL OUTCOMES; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN INJURY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; THERAPY DELAY; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; URINE VOLUME; ACUTE KIDNEY INJURY; BLOOD; CLINICAL TRIAL; CRITICAL ILLNESS; LENGTH OF STAY; MIDDLE AGED; SURVIVAL ANALYSIS; TIME FACTOR; VERY ELDERLY;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LIPOCALINS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; RENAL REPLACEMENT THERAPY; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84970021710     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.5828     Document Type: Article

References (40)

1. Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411-1423.
2. Bellomo R, Cass A, Cole L, et al; RENAL Replacement Therapy Study Investigators. Intensity of continuous renal replacement therapy in critically ill patients. N Engl J Med. 2009;361(17):1627-1638.
3. Palevsky PM, Zhang JH, O'Connor TZ, et al; VA/NIH Acute Renal Failure Trial Network. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7-20.
4. Jun. M, Heerspink HJ, Ninomiya T, et al. Intensities of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2010;5(6):956-963.
5. KDIGO AKI Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1-138.
6. Ronco C, Ricci Z, De Backer D, et al. Renal replacement therapy in acute kidney injury: controversy and consensus. Crit Care. 2015;19:146.
7. Karvellas CJ, Farhat MR, Sajjad I, et al. A comparison of early vs late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care. 2011;15(1):R72.
8. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med. 2002;30(10):2205-2211.
9. Jamale TE, Hase NK, Kulkarni M, et al. Earlier-start vs usual-start dialysis in patients with community-acquired acute kidney injury: a randomized controlled trial. Am J Kidney Dis. 2013;62(6):1116-1121.
10. Wald R, Adhikari NK, Smith OM, et al; Canadian Critical Care Trials Group. Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury. Kidney Int. 2015;88(4):897-904.
11. Gettings LG, Reynolds HN, Scalea T. Outcome in posttraumatic acute renal failure when continuous renal replacement therapy is applied early vs late. Intensive Care Med. 1999;25(8):805-813.
12. Bagshaw SM, Uchino S, Bellomo R, et al; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care. 2009;24(1):129-140.
13. Shiao CC, Wu VC, Li WY, et al; National Taiwan University Surgical Intensive Care Unit-Associated Renal Failure Study Group. Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery. Crit Care. 2009;13(5):R171.
14. Liu KD, Himmelfarb J, Paganini E, et al. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2006;1(5):915-919.
15. Chou YH, Huang TM, Wu VC, et al; NSARF Study Group. Impact of timing of renal replacement therapy initiation on outcome of septic acute kidney injury. Crit Care. 2011;15(3):R134.
16. Elahi MM, Lim MY, Joseph RN, Dhannapuneni RR, Spyt TJ. Early hemofiltration improves survival in postcardiotomy patients with acute renal failure. Eur J Cardiothorac Surg. 2004;26(5):1027-1031.
17. Demirkiliç U, Kuralay E, Yenicesu M, et al. Timing of replacement therapy for acute renal failure after cardiac surgery. J Card Surg. 2004;19(1):17-20.
18. Sugahara S, Suzuki H. Early start on continuous hemodialysis therapy improves survival rate in patients with acute renal failure following coronary bypass surgery. Hemodial Int. 2004;8(4):320-325.
19. Zarbock A, Gerß J, Van Aken H, Boanta A, Kellum JA, Meersch M. Early vs late initiation of renal replacement therapy in critically ill patients with acute kidney injury (the ELAIN trial): study protocol for a randomized controlled trial. Trials. 2016;17(1):148.
20. Wassmer G. Planning and analyzing adaptive group sequential survival trials. Biom J. 2006;48(4):714-729.
21. Lehmacher W, Wassmer G. Adaptive sample size calculations in group sequential trials. Biometrics. 1999;55(4):1286-1290.
22. Simmons EM, Himmelfarb J, Sezer MT, et al; PICARD Study Group. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int. 2004;65(4):1357-1365.
23. Murugan R, Karajala-Subramanyam V, Lee M, et al; Genetic and Inflammatory Markers of Sepsis (GenIMS) Investigators. Acute kidney injury in nonsevere pneumonia is associated with an increased immune response and lower survival. Kidney Int. 2010;77(6):527-535.
24. Gangemi S, Mallamace A, Minciullo PL, et al. Involvement of interleukin-18 in patients on maintenance haemodialysis. Am J Nephrol. 2002;22(5-6):417-421.
25. Bacher M, Metz CN, Calandra T, et al. An essential regulatory role for macrophage migration inhibitory factor in T cell activation. Proc Natl Acad Sci U S A. 1996;93(15):7849-7854.
26. Kellum JA, Mehta RL, Levin A, et al; Acute Kidney Injury Network (AKIN). Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, 3-step modified Delphi process. Clin J Am Soc Nephrol. 2008;3(3):887-894.
27. Gibney N, Hoste E, Burdmann EA, et al. Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions. Clin J Am Soc Nephrol. 2008;3(3):876-880.
28. Clark WR, Letteri JJ, Uchino S, Bellomo R, Ronco C. Recent clinical advances in the management of critically ill patients with acute renal failure. Blood Purif. 2006;24(5-6):487-498.
29. Matson J, Zydney A, Honoré PM. Blood filtration: new opportunities and the implications of systems biology. Crit Care Resusc. 2004;6(3):209-217.
30. Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10(3):R73.
31. Cruz DN, De Cal M, Garzotto F, et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med. 2010;36(3):444-451.
32. Cruz DN, De Geus HR, Bagshaw SM. Biomarker strategies to predict need for renal replacement therapy in acute kidney injury. Semin Dial. 2011;24(2):124-131.
33. Bouchard J, Soroko SB, Chertow GM, et al; Program to Improve Care in Acute Renal Disease (PICARD) Study Group. Fluid accumulation, survival, and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76(4):422-427.
34. Liu KD, Glidden DV, Eisner MD, et al; National Heart, Lung, and Blood Institute ARDS Network Clinical Trials Group. Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. Crit Care Med. 2007;35(12):2755-2761.
35. Kellum JA, Kong L, Fink MP, et al; GenIMS Investigators. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007;167(15):1655-1663.
36. Murugan R, Wen X, Shah N, et al; Biological Markers for Recovery of Kidney (BioMaRK) Study Investigators. Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy. Nephrol Dial Transplant. 2014;29(10):1854-1864.
37. Liu KD, Altmann C, Smits G, et al. Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study. Crit Care. 2009;13(4):R104.
38. Liangos O, Kolyada A, Tighiouart H, Perianayagam MC, Wald R, Jaber BL. Interleukin-8 and acute kidney injury following cardiopulmonary bypass: a prospective cohort study. Nephron Clin Pract. 2009;113(3):c148-c154.
39. Kwon O, Molitoris BA, Pescovitz M, Kelly KJ. Urinary actin, interleukin-6, and interleukin-8 may predict sustained ARF after ischemic injury in renal allografts. Am J Kidney Dis. 2003;41(5):1074-1087.
40. Chawla LS, Seneff MG, Nelson DR, et al. Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis. Clin J Am Soc Nephrol. 2007;2(1):22-30.